GU Cancers 2023 | Treatment sequencing and combinations for prostate cancer

Silke Gillessen, MD, Oncological Institute of Southern Switzerland, Bellinzona, Switzerland, talks on treatment sequencing and combinations for prostate cancer, including with androgen deprivation therapy (ADT), docetaxel and an endocrine agent in the metastatic hormone-sensitive setting. This interview took place at the ASCO GU Cancers Symposium 2023 in San Francisco, CA.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.